Setting the scene
By 1990, scientists recognized that sequencing the human genome—all 3 billion base pairs of DNA—would revolutionize medicine. The Human Genome Project was launched in 1990 as an international public effort led by the NIH and Department of Energy, with an estimated cost of $3 billion and 15-year timeline. The project used a methodical, map-first approach. In 1998, Craig Venter, a maverick scientist, announced his company Celera Genomics would sequence the genome faster and cheaper using whole-genome shotgun sequencing, sparking a race between public and private efforts.
What happened
On June 26, 2000, at a White House ceremony with President Bill Clinton and British Prime Minister Tony Blair, scientists announced a working draft of the human genome. Francis Collins of the public project and Craig Venter of Celera shared the stage, symbolizing a truce in their bitter rivalry. The draft covered about 90% of the genome. Clinton declared, 'Today we are learning the language in which God created life.' The announcement was timed to prevent Celera from patenting genes. The full sequence was published in 2001 in Nature and Science, and the complete genome was declared finished in 2003.
Why it still matters
The Human Genome Project revealed humans have about 20,000-25,000 genes, far fewer than expected, and that 98% of DNA is non-coding. It showed all humans are 99.9% genetically identical. The project launched the era of genomic medicine, enabling genetic testing for diseases, personalized medicine, and CRISPR gene editing. It cost $2.7 billion but has generated $1 trillion in economic impact. The project's open-data policy—releasing sequences daily—set a precedent for scientific sharing. It also raised ethical questions about genetic privacy and discrimination, leading to the Genetic Information Nondiscrimination Act in 2008. The genome sequence remains the foundation of modern biology.
Background
The project advanced biomedical research and genomics tools.